Contrast Injector Systems Market - Rapid Rise in Geriatric Population As Well As the Growth in Number of Chronic Diseases in the Developing Economies Boost the Market Growth

The Contrast Injector Systems Market is expected to reach $ 956.62 million in 2023, an annual average growth rate of 8.1% from 2017 to 2023.

Consumables accounted for about half of the global market share in 2016.
The Contrast injector system improves the visibility of body structures such as body fluids, tissues, bones, veins and arteries for diagnosis of diseases and disorders. The contrast injector system uses a contrast agent that enhances the body structure described above. Visualization of various pathologies is performed through imaging procedures such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/3977

Increasing numbers of chronic diseases such as cancer, Alzheimer's and dementia lead to improved imaging procedures leading the market. However, the high cost of the contrast injector system and the high risk associated with the contrast injector system, especially the use of media, hamper market growth. In addition, increased health spending and the emergence of complex diseases in developing countries create opportunities for key market participants.

The key players operating in the contrast injector system market adopted product launch as one of their key developmental strategies, such as business expansion, product development, and business acquisition.

The major companies profiled in the report include
• Bracco Imaging S.p.A
• Bayer HealthCare
• Guerbet Group
• Medtron AG
• Ulrich GmbH & Co. KG
• GE Healthcare
• Shenzhen Seacrown Electromechanical Co. Ltd
• Nemoto Kyorindo Co. Ltd.
• Sino Medical- Device Technology Co. Ltd.
• Vivid Imaging.

Other prominent players in the value chain analysis include Imaxeon, Pty Ltd, Network Imaging Systems, IRadimed Corporation, Covidien, Agito Medical, and Merit Medical Systems.

The CT Injector Systems segment generated the highest revenue in 2016, accounting for approximately half of the total market share in 2016. This is due to an increase in imaging procedures through CT scans and an increase in the sophistication of the CT injector system. However, the angiographic injector system is expected to grow to the fastest CAGR of 8.7% over the forecast period. This is because of an increase in the number of heart disease and an increased burden of diagnosing heart failure at an early stage.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/3977

Of the end users, hospitals had the highest total revenue in 2016, accounting for 32.9% of the total injector system market share and expected to continue this trend throughout the forecast period. In addition, due to the increasing trend of imaging procedures in the diagnostic center sector, the diagnostic center sector is expected to show a high growth rate of 8.9%. Your doctor's recommendation for CT and MRI scans at the diagnostic center further improves the global syringe system market.

Key Findings of the Contrast Injector Systems Market:
• The injector systems segment accounted for about two-fifths share of the total market in 2016 and is expected to grow with a high CAGR of 8.7% during the forecast period.
• The interventional cardiology segment is the fastest growing application in the global market, registering a CAGR of 9.2% during the forecast period.
• The U.S. dominated the global contrast injector systems market and is projected to grow at a CAGR of 5.3% from 2017 to 2023.
• India was the fastest growing country in the Asia-Pacific contrast injector systems market in 2016, registering a CAGR of 11.7%, and is anticipated to continue this trend during the forecast period.
• The hospitals segment contributed to the highest market share in 2016, registering a CAGR of 8.1% from 2017 to 2023.

Asia-Pacific is expected to witness highest growth rate for contrast injector system market throughout the forecast period, and is expected to continue this trend, owing to high population density in countries such as India and China.

Access Full Summery @ https://www.alliedmarketresearch.com/contrast-injector-systems-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.